Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-023418
Filing Date
2025-07-24
Accepted
2025-07-25 10:26:15
Documents
4
Period of Report
2025-09-05

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A vxrt20250717_pre14a.htm PRE 14A 210438
2 cm01.jpg GRAPHIC 3753
3 image1.jpg GRAPHIC 142525
4 image2.jpg GRAPHIC 128025
  Complete submission text file 0001437749-25-023418.txt   589682
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35285 | Film No.: 251149615
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)